BioXcel Therapeutics (BTAI) Amortizatization of Intangibles (2023 - 2025)

BioXcel Therapeutics has reported Amortizatization of Intangibles over the past 3 years, most recently at $84000.0 for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at $84000.0 for Q4 2025, up 6.33% from a year ago — trailing twelve months through Dec 2025 was $326000.0 (up 6.54% YoY), and the annual figure for FY2025 was $326000.0, up 6.54%.
  • Amortizatization of Intangibles for Q4 2025 was $84000.0 at BioXcel Therapeutics, up from $82000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for BTAI hit a ceiling of $84000.0 in Q4 2025 and a floor of $70000.0 in Q1 2023.
  • Median Amortizatization of Intangibles over the past 3 years was $76000.0 (2024), compared with a mean of $76666.7.
  • Biggest five-year swings in Amortizatization of Intangibles: rose 4.17% in 2024 and later rose 8.0% in 2025.
  • BioXcel Therapeutics' Amortizatization of Intangibles stood at $74000.0 in 2023, then grew by 6.76% to $79000.0 in 2024, then grew by 6.33% to $84000.0 in 2025.
  • The last three reported values for Amortizatization of Intangibles were $84000.0 (Q4 2025), $82000.0 (Q3 2025), and $81000.0 (Q2 2025) per Business Quant data.